NuvaRing Lawyer Reports on Case Decisions As To Experts

NuvaRing Lawyer

NuvaRing Attorneys Report That Patients May Be Injured

As attorneys who are providing free nationwide case evaluations to women or their loved ones who have experienced injuries while using the NuvuRing product, we thought it worthwhile to advise about an order from the Judge in the multi-district litigation on one of plaintiff’s experts.

The Judge overseeing the federal NuvaRing multi-district litigation granted Organon’s USA, Inc.’s motion to exclude plaintiff’s expert that NuvaRing and other combined hormonal contraceptives containing third generation progestin should be taken off the market.  The court held that such testimony is not based upon a sound methodology.

NuvaRing is made by Organon and is a combined hormonal contraceptive that releases hormones over the course of treatment.  Plaintiffs claim that the third generation progestin used in NuvaRing has been linked to undisclosed higher risk for deep vein thrombosis and pulmonary embolism.  Plaintiffs have asserted claims for strict liability, including defective manufacturing, defective design, failure to test and inadequate warnings.  Plaintiffs have likewise brought claims for breach of express warranty, breach of implied warranty and negligence.

The particular expert in question is Dr. Scott Roseff, who opined that the NuvaRing should be removed from the market.  Roseff testified that the risks presented by the NuvaRing are so great that the entire generation of contraceptives should be removed from the marketplace.  Organon asserted in their motion that this testimony was unreliable and should be excluded at trial.  The judge agreed and will not allow this particular form of expert testimony.

It is worth noting that the particular ruling by the court as it to this particular expert does not change the fact that the same court has allowed the plaintiffs to put forward a host of other expert opinions, all of which will be admissible to show that the product can cause harm to patients.

If you or a loved one has been injured by the NuvaRing product including because of suffering from deep vein thrombosis or pulmonary embolism, please contact us immediately.

Side Effects

Some women who have had NuvaRing implanted experienced serious and even debilitating or life-threatening side-effects. Serious side effects that have been linked to NuvaRing include:

  • Blood clots
  • Cerebral thrombosis
  • Deep vein thrombosis (DVT)
  • Heart attack or myocardial infarction (MI)
  • Pulmonary embolism
  • Retinal thrombosis
  • Stroke or cerebral hemorrhage
  • Thrombophlebitis and venous thrombosis with or without embolism
  • Toxic shock syndrome (TSS)

If you experienced adverse NuvaRing side effects or have a loved one who suffered injury following the implantation of NuvaRing, you may have a potential NuvaRing lawsuit.

More Information

Approved by the Food and Drug Administration (FDA) in 2001, NuvaRing is a non-biodegradable, latex-free, flexible vaginal ring containing a combination of the hormones estrogen (ethinyl estradiol) and progestin (etonogestrel). Etonogestrel is the active metabolite of desogestrel, a synthetic form of the naturally occurring female sex hormone progesterone. The NuvaRing contraceptive ring is designed to prevent pregnancy by releasing a steady dose of the hormone combination into the bloodstream through the vaginal walls over the course of 21 days. The hormones prevent ovulation, change the cervical mucus to prevent sperm penetration, and thin the lining of the uterus to, theoretically, prevent sperm implantation.

In October 2003, The New England Journal of Medicine addressed research suggesting that, when taken orally, desogestrel can significantly increase the risk of blood clots. If left untreated, such blood clots can develop into more serious conditions that may include stroke, heart attack, pulmonary embolism, or deep vein thrombosis. These findings, as well as those from other studies, were based upon analysis of the effect of oral contraceptives containing desogestrel.

A Swiss report was released in June 2010 which claimed there were approximately 40 deaths reported in the FDA database of adverse events associated with Nuvaring.   The current label and package insert for NuvaRing refers only to studies conducted on women using combination oral contraceptives and suggests that adverse reactions associated with the use of combination hormonal oral contraceptives are likely to apply to combination vaginal contraceptives like NuvaRing. The label, however, states that there is no available epidemiologic data to determine whether the safety and efficacy of vaginal administration of combination hormonal contraceptives differs from oral administration. To date, there is no comprehensive study of NuvaRing and the long-term health effects of its vaginally delivered combination.

Our team of attorneys are now investigating claims and prepared to file NuvaRing lawsuits involving the vaginal ring contraceptive medication NuvaRing®. NuvaRing is manufactured by New Jersey-based Organon USA, Inc., a company that Schering-Plough Corporation acquired in 2007, and has been linked to serious events such as blood clotspulmonary embolismstroke and heart attack.Call us today at 1-800-632-1404 for a FREE CONSULTATION.

No Recovery, No Fee

We take NuvaRing litigation cases on a contingency basis. That means that there is no cost to you unless we and our co-counsel are able to recover a settlement or judgment on your behalf. So, unless your case is resolved by trial, arbitration, settlement, or other resolution, you do not have to pay any attorney fees to us, or pay any costs. Litigation costs include filing fees, court reporter fees for deposition, copying costs, experts, and travel. Litigation costs are paid by our firm so you don’t have to have cash to pursue justice against medical device corporations.

About us

Our team of attorneys have been retained by clients across the world as to allegedly defective and improperly designed medical devices and prescription drugs.  In fact, our team of attorneys has represented patients around the globe for the allegedly defective Advanced Bionics HiRes90k cochlear implant device and other medical devices including the DePuy hip implant, the Mirena IUD and the transvaginal mesh and transvaginal sling devices including from C.R. Bard, AMS, Boston Scientific and Johnson & Johnson’s Ethicon.

As a NuvaRing attorney, we will investigate your claim and with our co-counsel we stand ready to push your case ahead.

FOR A FREE CASE EVALUATION:

CALL TOLL FREE: (800) 632-1404

EMAIL: clicking here.

FILL OUT THIS FORM FOR FREE HELP:

    Your Name (required)

    Your Email (required)

    Your Phone Number (required)

    Case Details

    captcha

    NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

    Leave a Reply

    Your email address will not be published. Required fields are marked *